rs2307129

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000637337.1(AGL):​n.261C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.18 in 1,611,300 control chromosomes in the GnomAD database, including 28,789 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 5046 hom., cov: 32)
Exomes 𝑓: 0.17 ( 23743 hom. )

Consequence

AGL
ENST00000637337.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.01

Publications

17 publications found
Variant links:
Genes affected
AGL (HGNC:321): (amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase) This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
AGL Gene-Disease associations (from GenCC):
  • glycogen storage disease III
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Laboratory for Molecular Medicine, Myriad Women’s Health, Orphanet, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-99861470-C-T is Benign according to our data. Variant chr1-99861470-C-T is described in ClinVar as [Benign]. Clinvar id is 256750.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.385 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGLNM_000642.3 linkc.83-33C>T intron_variant Intron 2 of 33 ENST00000361915.8 NP_000633.2 P35573-1A0A0S2A4E4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGLENST00000361915.8 linkc.83-33C>T intron_variant Intron 2 of 33 1 NM_000642.3 ENSP00000355106.3 P35573-1

Frequencies

GnomAD3 genomes
AF:
0.235
AC:
35761
AN:
151892
Hom.:
5048
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.390
Gnomad AMI
AF:
0.219
Gnomad AMR
AF:
0.188
Gnomad ASJ
AF:
0.247
Gnomad EAS
AF:
0.119
Gnomad SAS
AF:
0.195
Gnomad FIN
AF:
0.195
Gnomad MID
AF:
0.306
Gnomad NFE
AF:
0.170
Gnomad OTH
AF:
0.229
GnomAD2 exomes
AF:
0.184
AC:
45917
AN:
249460
AF XY:
0.183
show subpopulations
Gnomad AFR exome
AF:
0.386
Gnomad AMR exome
AF:
0.131
Gnomad ASJ exome
AF:
0.254
Gnomad EAS exome
AF:
0.122
Gnomad FIN exome
AF:
0.192
Gnomad NFE exome
AF:
0.171
Gnomad OTH exome
AF:
0.197
GnomAD4 exome
AF:
0.175
AC:
254822
AN:
1459290
Hom.:
23743
Cov.:
33
AF XY:
0.175
AC XY:
127188
AN XY:
725964
show subpopulations
African (AFR)
AF:
0.397
AC:
13241
AN:
33384
American (AMR)
AF:
0.140
AC:
6229
AN:
44610
Ashkenazi Jewish (ASJ)
AF:
0.247
AC:
6450
AN:
26090
East Asian (EAS)
AF:
0.111
AC:
4395
AN:
39614
South Asian (SAS)
AF:
0.189
AC:
16280
AN:
86026
European-Finnish (FIN)
AF:
0.193
AC:
10307
AN:
53356
Middle Eastern (MID)
AF:
0.297
AC:
1708
AN:
5744
European-Non Finnish (NFE)
AF:
0.166
AC:
184664
AN:
1110182
Other (OTH)
AF:
0.192
AC:
11548
AN:
60284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
10363
20726
31088
41451
51814
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6690
13380
20070
26760
33450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.235
AC:
35761
AN:
152010
Hom.:
5046
Cov.:
32
AF XY:
0.234
AC XY:
17424
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.390
AC:
16140
AN:
41426
American (AMR)
AF:
0.187
AC:
2856
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.247
AC:
855
AN:
3466
East Asian (EAS)
AF:
0.119
AC:
617
AN:
5188
South Asian (SAS)
AF:
0.194
AC:
937
AN:
4818
European-Finnish (FIN)
AF:
0.195
AC:
2058
AN:
10554
Middle Eastern (MID)
AF:
0.288
AC:
84
AN:
292
European-Non Finnish (NFE)
AF:
0.170
AC:
11539
AN:
67972
Other (OTH)
AF:
0.225
AC:
475
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1326
2652
3978
5304
6630
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.192
Hom.:
13835
Bravo
AF:
0.238
Asia WGS
AF:
0.165
AC:
573
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 02, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Glycogen storage disease type III Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
4.1
DANN
Benign
0.62
PhyloP100
-1.0
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2307129; hg19: chr1-100327026; COSMIC: COSV54053030; API